Increased vascular wall thrombogenicity combined with reduced blood flow promotes occlusive thrombus formation in rabbit femoral artery

被引:43
作者
Yamashita, A
Furukoji, E
Marutsuka, K
Hatakeyama, K
Yamamoto, H
Tamura, S
Ikeda, Y
Sumiyoshi, A
Asada, Y
机构
[1] Miyazaki Univ, Miyazaki Med Coll, Dept Pathol 1, Miyazaki 8891692, Japan
[2] Miyazaki Univ, Miyazaki Med Coll, Dept Radiol, Miyazaki 8891692, Japan
[3] Ajinomoto Co Inc, Pharmaceut Res Labs, Kawasaki, Kanagawa, Japan
[4] Keio Univ, Sch Med, Dept Med Hematol, Tokyo, Japan
关键词
thrombus propagation; blood flow; von Willebrand factor; tissue factor;
D O I
10.1161/01.ATV.0000147767.61336.de
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Plaque disruption does not always result in complete thrombotic occlusion. The mechanism of arterial thrombus propagation remains unclear. Methods and Results - We studied how vascular wall thrombogenicity and blood flow reduction affect thrombus propagation using a rabbit model of single and repeated balloon injury. After balloon injury of the normal femoral artery, the blood flow was reduced to 50%, 25%, or 10% ( n = 5). Small mural thrombi composed of aggregated platelets were produced, but no occlusive thrombi developed in any flow reduction. Three weeks after the first balloon injury, neointima with tissue factor expression and increased procoagulant activity was developed. Balloon injury of the neointima with the same blood flow reduction ( n = 5) induced fibrin-rich thrombus formation. Additionally, injury with flow reduced to 25% and 10% promoted thrombus propagation resulting in vessel occlusion within 160 +/- 18 and 71 +/- 17 seconds, respectively. An injection of anti-von Willebrand factor (vWF) monoclonal antibody (AJW200; 1.0 mg/kg) prevented occlusive thrombus formation. Conclusions - Increased vascular wall thrombogenicity together with a substantial blood flow reduction is crucial for occlusive thrombus formation, and vWF plays an important role in thrombus propagation. Reduced blood flow at plaque disruption sites might contribute to thrombus propagation leading to acute coronary syndromes.
引用
收藏
页码:2420 / 2424
页数:5
相关论文
共 36 条
[1]   Platelets adhere to and translocate on von Willebrand factor presented by endothelium in simulated veins [J].
André, P ;
Denis, CV ;
Ware, J ;
Saffaripour, S ;
Hynes, RO ;
Ruggeri, ZM ;
Wagner, DD .
BLOOD, 2000, 96 (10) :3322-3328
[2]   CORONARY-THROMBOSIS IN NONCARDIAC DEATH [J].
ARBUSTINI, E ;
GRASSO, M ;
DIEGOLI, M ;
MORBINI, P ;
AGUZZI, A ;
FASANI, R ;
SPECCHIA, G .
CORONARY ARTERY DISEASE, 1993, 4 (09) :751-759
[3]   Fibrin-rich and platelet-rich thrombus formation on neointima: Recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta [J].
Asada, Y ;
Hara, S ;
Tsuneyoshi, A ;
Hatakeyama, K ;
Kisanuki, A ;
Marutsuka, K ;
Sato, Y ;
Kamikubo, Y ;
Sumiyoshi, A .
THROMBOSIS AND HAEMOSTASIS, 1998, 80 (03) :506-511
[4]   Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus-mediated local TFPI gene transfer additively reduces neointima formation in balloon-injured rabbit carotid arteries [J].
Atsuchi, N ;
Nishida, T ;
Marutsuka, K ;
Asada, Y ;
Kamikubo, Y ;
Takeshita, A ;
Ueno, H .
CIRCULATION, 2001, 103 (04) :570-575
[5]   Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques - Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions [J].
Badimon, JJ ;
Lettino, M ;
Toschi, V ;
Fuster, V ;
Berrozpe, M ;
Chesebro, JH ;
Badimon, L .
CIRCULATION, 1999, 99 (14) :1780-1787
[6]   Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque [J].
Bonderman, D ;
Teml, A ;
Jakowitsch, J ;
Adlbrecht, C ;
Gyöngyösi, M ;
Sperker, W ;
Lass, H ;
Mosgoeller, W ;
Glogar, DH ;
Probst, P ;
Maurer, G ;
Nemerson, Y ;
Lang, IM .
BLOOD, 2002, 99 (08) :2794-2800
[7]   Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs [J].
Camera, M ;
Frigerio, M ;
Toschi, V ;
Brambilla, M ;
Rossi, F ;
Cottell, DC ;
Maderna, P ;
Parolari, A ;
Bonzi, R ;
De Vincenti, O ;
Tremoli, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (09) :1690-1696
[8]   INTRAMYOCARDIAL PLATELET-AGGREGATION IN PATIENTS WITH UNSTABLE ANGINA SUFFERING SUDDEN ISCHEMIC CARDIAC DEATH [J].
DAVIES, MJ ;
THOMAS, AC ;
KNAPMAN, PA ;
HANGARTNER, JR .
CIRCULATION, 1986, 73 (03) :418-427
[9]   Stability and instability: Two faces of coronary atherosclerosis - The Paul Dudley White Lecture 1995 [J].
Davies, MJ .
CIRCULATION, 1996, 94 (08) :2013-2020
[10]   THROMBOSIS AND ACUTE CORONARY-ARTERY LESIONS IN SUDDEN CARDIAC ISCHEMIC DEATH [J].
DAVIES, MJ ;
THOMAS, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (18) :1137-1140